Patents Assigned to APROGEN MEDICINES INC.
  • Antibody binding to carbonic anhydrase and use thereof
    Patent number: 11192959
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: December 7, 2021
    Assignee: APROGEN MEDICINES INC.
    Inventors: Yoo Ri Moon, Sangsoon Yoon, Jeong Won Hong, Eun Jung Kim, Da Bin Choi